Jasper Therapeutics, Inc.

JSPR

—

Advanced chart & tools →

Jasper Therapeutics, Inc.JSPR

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-3.95

Dividend yield

0.00%

Dividend / share

$0.04

Revenue

—

Net income

$-75.80M

Net margin

—

Gross margin

—

Dividends & financials

Jasper Therapeutics, Inc. (JSPR) reported revenue of — and net income of $-75.80M, or $-3.95 per diluted share. It pays an annual dividend of $0.04 per share — a yield of 0.00% at the current price. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.